244.46
-7.65(-3.03%)
Currency In USD
| Previous Close | 252.11 |
| Open | 250.04 |
| Day High | 251.17 |
| Day Low | 244.45 |
| 52-Week High | 293.81 |
| 52-Week Low | 199.92 |
| Volume | 868,162 |
| Average Volume | 1.06M |
| Market Cap | 35.83B |
| PE | 25 |
| EPS | 9.78 |
| Moving Average 50 Days | 266.19 |
| Moving Average 200 Days | 251.82 |
| Change | -7.65 |
If you invested $1000 in ResMed Inc. (RMD) 10 years ago, it would be worth $4,770.88 as of November 16, 2025 at a share price of $244.46. Whereas If you bought $1000 worth of ResMed Inc. (RMD) shares 5 years ago, it would be worth $1,173.26 as of November 16, 2025 at a share price of $244.46.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025
GlobeNewswire Inc.
Oct 09, 2025 8:05 PM GMT
SAN DIEGO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2026 on Thursday, October 30, 2025, after the New York Stock Exchan
Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025
GlobeNewswire Inc.
Sep 16, 2025 8:05 PM GMT
SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the Bank of America Global Healthcare Confer
Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority
GlobeNewswire Inc.
Sep 03, 2025 8:15 PM GMT
New global clinical insights initiative debuts at World Sleep Congress 2025 to help drive innovation in sleep health careSAN DIEGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sl